The National Institutes of Health is terminating dozens of studies examining why people are hesitant about vaccines and how ...

Christopher Ridley, a spokesperson for Moderna, said the state legislative efforts are largely a product of ...

The mRNA technology faces growing doubts among Republicans, including people around President Donald Trump. Legislation aimed ...

Moderna (NASDAQ:MRNA) shares jumped 16% on Wednesday, March 5, following a favorable German court decision that determined ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...

On the five-year anniversary of the Covid pandemic, a Times reporter, Apoorva Mandavilli, looks back at the success of, and the backlash to, the mRNA vaccine. There’s no question that this vaccine ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

Mainz Biomed Enters into Exclusive Licensing Agreement for the Portfolio of mRNA Biomarkers, with Continued Development of ...

A bill banning gene-based vaccines, like some forms of the COVID-19 vaccine, received approval from a Senate subcommittee ...

Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...

Moderna (NasdaqGS:MRNA) recently faced significant legal challenges with five international lawsuits from Genevant Sciences and Arbutus Biopharma targeting its LNP technology used in products like ...

A bill to make it a crime to administer mRNA vaccines in Iowa — like the Moderna and Pfizer COVID shots — has cleared initial ...